A phase 3 clinical trial led at UCLA by Dr. April Armstrong helped show that the once-daily oral medication icotrokinra is a safe, effective alternative to injectable therapies for moderate to severe psoriasis. Read the full story: uclahs.fyi/4hZPOEx
A phase 3 clinical trial led at UCLA by Dr. April Armstrong helped show that the once-daily oral medication icotrokinra is a safe, effective alternative to injectable therapies for moderate to severe psoriasis. Read the full story: uclahs.fyi/4hZPOEx